Effect of SLGT2 Inhibitors on Patients with Atrial Fibrillation.
Justin HalootLucijana KrokarAuroa Badin
Published in: Journal of atrial fibrillation (2021)
In patients with AF, use of SGLT2 inhibitors was associated with a lower risk of cardioversion and all-cause mortality and higher probability of survival based on Kaplan-Meier analysis.